Supplemental
Capital expenditures incurred but not yet paid
Medline, Inc. Capital expenditures incurred but not yet paid remained flat by 0.0% to $14.5M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 16.0%, from $12.5M to $14.5M. Over 2 years (FY 2023 to FY 2025), Capital expenditures incurred but not yet paid shows an upward trend with a 52.3% CAGR.
Analysis
StatementCash Flow Statement
SectionSupplemental
First reportedQ1 2023
Last reportedQ4 2025Feb 25, 2026
Metric ID:
nflx_capex_incurred_not_paidHistorical Data
3 years
| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $25M | $50M | $58M |
| YoY Change | — | +100.0% | +16.0% |
Range$25M – $58M
CAGR+52.3%
Avg YoY Growth+58.0%
Median YoY Growth+58.0%
Current Streak2+ years growth
Capital expenditures incurred but not yet paid at Other Companies
Frequently Asked Questions
- What is Medline, Inc. 's capital expenditures incurred but not yet paid?
- Medline, Inc. (MDLN) reported capital expenditures incurred but not yet paid of $14.5M in Q4 2025.
- How has Medline, Inc. 's capital expenditures incurred but not yet paid changed year-over-year?
- Medline, Inc. 's capital expenditures incurred but not yet paid increased by 16.0% year-over-year, from $12.5M to $14.5M.
- What is the long-term trend for Medline, Inc. 's capital expenditures incurred but not yet paid?
- Over 2 years (2023 to 2025), Medline, Inc. 's capital expenditures incurred but not yet paid has grown at a 52.3% compound annual growth rate (CAGR), from $25M to $58M.